prasugrel 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
platelet aggregation inhibitors 4113 150322-43-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • prasugrel
  • prasugrel hydrochloride
  • effient
  • efient
  • prasugrel HCl
  • CS-747
  • LY640315
A piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS.
  • Molecular weight: 373.44
  • Formula: C20H20FNO3S
  • CLOGP: 3.46
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 0
  • TPSA: 46.61
  • ALOGS: -5.20
  • ROTB: 6
  • Status: OFP
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
10 mg O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 2 Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 1 % Benet LZ, Broccatelli F, Oprea TI
BA (Bioavailability) 75 %

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2B,AKT2,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DYRK1B,EIF2AK3,EPHB4,ERBB2,GRK2,ITK,JAK2,MAP3K7,MAPK10,MAPK7,MAPKAPK2,MET,NTRK2,PDK1,PDK4,PDPK1,PIK3CA,PIK3CB,PIM2,PRKDC,STK33,TEK,TTK 33
kinase-selectivity-class AXL,BRAF,GRK2 3
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

DateAgencyCompanyOrphan
Feb. 24, 2009 EMA DAIICHI SANKYO EUROPE GMBH
July 10, 2009 FDA ELI LILLY AND CO
March 24, 2014 PMDA DAIICHI SANKYO COMPANY, LIMITED

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Myocardial infarction 199.72 21.73 102 4731 105870 90517744
Acute myocardial infarction 143.68 21.73 58 4775 34832 90588782
Thrombosis in device 142.32 21.73 33 4800 3042 90620572
Vascular pseudoaneurysm 109.72 21.73 24 4809 1699 90621915
Vascular stent stenosis 93.91 21.73 18 4815 658 90622956
Gastrointestinal haemorrhage 88.99 21.73 57 4776 90191 90533423
Coronary artery occlusion 75.61 21.73 25 4808 8529 90615085
Coronary artery restenosis 72.70 21.73 13 4820 322 90623292
Coronary artery disease 67.94 21.73 34 4799 33589 90590025
Haemorrhage 66.34 21.73 43 4790 69326 90554288
Angina unstable 63.63 21.73 21 4812 7122 90616492
Angina pectoris 63.05 21.73 34 4799 39126 90584488
Coronary artery stenosis 48.99 21.73 16 4817 5250 90618364
Cerebrovascular arteriovenous malformation 44.16 21.73 7 4826 81 90623533
Myopathy 43.92 21.73 19 4814 13499 90610115
Aneurysm 42.01 21.73 13 4820 3587 90620027
Cerebral haemorrhage 39.52 21.73 24 4809 34498 90589116
Chest pain 39.29 21.73 65 4768 319580 90304034
Haematoma 39.27 21.73 25 4808 39023 90584591
Platelet function test abnormal 37.07 21.73 6 4827 80 90623534
Retroperitoneal haemorrhage 35.42 21.73 11 4822 3069 90620545
Crush syndrome 35.38 21.73 7 4826 302 90623312
Peripheral arterial occlusive disease 34.89 21.73 12 4821 4609 90619005
Acute coronary syndrome 34.48 21.73 15 4818 10798 90612816
Phaeochromocytoma crisis 34.07 21.73 7 4826 366 90623248
Cardiogenic shock 33.23 21.73 19 4814 24449 90599165
Somnambulism 31.39 21.73 12 4821 6216 90617398
Coronary artery thrombosis 31.09 21.73 8 4825 1134 90622480
Photopsia 30.15 21.73 11 4822 5013 90618601
Device occlusion 30.00 21.73 13 4820 9269 90614345
Stent placement 28.22 21.73 10 4823 4193 90619421
Cerebellar haemorrhage 28.16 21.73 8 4825 1645 90621969
Coronary arterial stent insertion 27.92 21.73 9 4824 2831 90620783
Puncture site haemorrhage 27.89 21.73 6 4827 392 90623222
Epistaxis 27.54 21.73 28 4805 85097 90538517
Subarachnoid haemorrhage 27.29 21.73 15 4818 17889 90605725
Factor V inhibition 26.55 21.73 5 4828 166 90623448
Haemorrhage subcutaneous 26.34 21.73 9 4824 3387 90620227
Myalgia 26.18 21.73 39 4794 175086 90448528
Subdural haematoma 25.52 21.73 14 4819 16631 90606983
Thrombosis 25.36 21.73 25 4808 73226 90550388
Intraventricular haemorrhage 24.99 21.73 8 4825 2461 90621153
Thrombotic cerebral infarction 24.63 21.73 5 4828 246 90623368
Rhabdomyolysis 24.59 21.73 21 4812 51235 90572379
Labelled drug-drug interaction medication error 24.41 21.73 13 4820 14569 90609045
Cerebral infarction 24.21 21.73 16 4817 26580 90597034
Cardiac failure congestive 24.12 21.73 28 4805 98666 90524948
Tachycardia paroxysmal 23.21 21.73 5 4828 329 90623285
Coagulation factor V level decreased 22.81 21.73 5 4828 357 90623257
Eye haemorrhage 22.65 21.73 11 4822 10169 90613445
Ocular retrobulbar haemorrhage 21.93 21.73 4 4829 111 90623503
Vascular stent thrombosis 21.74 21.73 6 4827 1110 90622504

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Thrombosis in device 358.53 17.77 91 8840 3055 42609349
Vascular stent thrombosis 341.14 17.77 88 8843 3154 42609250
Vascular stent stenosis 217.05 17.77 50 8881 1102 42611302
Acute myocardial infarction 207.54 17.77 137 8794 58028 42554376
Myocardial infarction 193.75 17.77 179 8752 123830 42488574
Angina pectoris 125.78 17.77 81 8850 32815 42579589
Chest pain 123.69 17.77 149 8782 139381 42473023
Coronary artery restenosis 87.15 17.77 23 8908 899 42611505
Angina unstable 77.86 17.77 41 8890 11407 42600997
Coronary artery stenosis 72.95 17.77 38 8893 10341 42602063
Haemorrhage 72.95 17.77 76 8855 60487 42551917
Gastrointestinal haemorrhage 66.99 17.77 92 8839 97634 42514770
Haemorrhage intracranial 62.39 17.77 41 8890 17151 42595253
Labelled drug-drug interaction medication error 58.60 17.77 38 8893 15544 42596860
Cardiac tamponade 57.89 17.77 28 8903 6512 42605892
Haematoma 52.60 17.77 45 8886 27978 42584426
Vascular pseudoaneurysm 48.27 17.77 19 8912 2693 42609711
Coronary artery occlusion 46.79 17.77 29 8902 10968 42601436
Coronary artery thrombosis 40.63 17.77 16 8915 2270 42610134
Myocardial ischaemia 38.48 17.77 31 8900 17731 42594673
Pericardial haemorrhage 36.87 17.77 17 8914 3552 42608852
Cerebral haemorrhage 35.02 17.77 42 8889 38924 42573480
Acute coronary syndrome 34.46 17.77 27 8904 14838 42597566
Epistaxis 32.98 17.77 54 8877 66772 42545632
Coronary artery disease 32.94 17.77 48 8883 53672 42558732
Device occlusion 32.73 17.77 21 8910 8429 42603975
Intraventricular haemorrhage 32.48 17.77 16 8915 3868 42608536
Melaena 31.96 17.77 40 8891 38706 42573698
Apnoeic attack 30.89 17.77 9 8922 508 42611896
Abdominal symptom 29.82 17.77 9 8922 574 42611830
Subdural haematoma 29.56 17.77 30 8901 23108 42589296
Upper gastrointestinal haemorrhage 29.45 17.77 34 8897 30265 42582139
Pulmonary alveolar haemorrhage 28.21 17.77 24 8907 14792 42597612
Cardiac failure 27.84 17.77 66 8865 106790 42505614
Stent placement 27.64 17.77 16 8915 5344 42607060
Thrombotic thrombocytopenic purpura 26.93 17.77 14 8917 3790 42608614
Arterial restenosis 25.03 17.77 5 8926 54 42612350
Obstructive shock 24.86 17.77 5 8926 56 42612348
Peripheral arterial occlusive disease 24.05 17.77 16 8915 6822 42605582
Toxicity to various agents 24.03 17.77 9 8922 229127 42383277
Arterial injury 23.59 17.77 7 8924 421 42611983
Thrombotic cerebral infarction 22.96 17.77 7 8924 462 42611942
Vascular stent occlusion 22.82 17.77 6 8925 231 42612173
Shock haemorrhagic 22.48 17.77 22 8909 16220 42596184
Non-cardiac chest pain 21.98 17.77 13 8918 4516 42607888
Febrile neutropenia 21.76 17.77 6 8925 185697 42426707
Platelet function test abnormal 21.41 17.77 5 8926 117 42612287
Neutropenia 20.63 17.77 8 8923 199423 42412981
Spinal epidural haematoma 19.33 17.77 6 8925 421 42611983
Coombs negative haemolytic anaemia 19.29 17.77 5 8926 182 42612222
Procedural haemorrhage 18.81 17.77 10 8921 2831 42609573
Melanaemia 18.81 17.77 4 8927 60 42612344
Myocardial rupture 18.50 17.77 5 8926 214 42612190
Gastric ulcer haemorrhage 18.39 17.77 13 8918 6114 42606290
Vessel puncture site haematoma 17.87 17.77 4 8927 77 42612327
Coronary artery perforation 17.87 17.77 4 8927 77 42612327

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Vascular stent thrombosis 374.05 15.87 87 11563 4074 110573575
Myocardial infarction 314.97 15.87 215 11435 191868 110385781
Acute myocardial infarction 304.71 15.87 157 11493 83620 110494029
Thrombosis in device 283.17 15.87 73 11577 5254 110572395
Vascular stent stenosis 137.54 15.87 32 11618 1497 110576152
Gastrointestinal haemorrhage 135.21 15.87 123 11527 165395 110412254
Coronary artery stenosis 125.06 15.87 49 11601 13709 110563940
Vascular pseudoaneurysm 122.94 15.87 36 11614 4154 110573495
Haemorrhage 115.05 15.87 93 11557 106599 110471050
Angina pectoris 107.21 15.87 72 11578 62223 110515426
Chest pain 96.54 15.87 155 11495 376220 110201429
Coronary artery occlusion 88.97 15.87 40 11610 15732 110561917
Haematoma 82.86 15.87 60 11590 58416 110519233
Coronary artery disease 82.61 15.87 65 11585 71625 110506024
Labelled drug-drug interaction medication error 81.44 15.87 46 11604 29256 110548393
Coronary artery restenosis 76.51 15.87 19 11631 1173 110576476
Angina unstable 75.03 15.87 36 11614 16396 110561253
Haemorrhage intracranial 68.63 15.87 41 11609 28928 110548721
Cerebral haemorrhage 66.56 15.87 55 11595 64913 110512736
Acute coronary syndrome 63.46 15.87 36 11614 23076 110554573
Intraventricular haemorrhage 62.24 15.87 23 11627 5484 110572165
Coronary artery thrombosis 57.70 15.87 19 11631 3225 110574424
Epistaxis 54.64 15.87 68 11582 130304 110447345
Peripheral arterial occlusive disease 53.82 15.87 24 11626 9256 110568393
Device occlusion 50.93 15.87 27 11623 15158 110562491
Stent placement 49.42 15.87 21 11629 7213 110570436
Pulmonary alveolar haemorrhage 46.38 15.87 28 11622 20122 110557527
Upper gastrointestinal haemorrhage 46.35 15.87 40 11610 50056 110527593
Subdural haematoma 46.23 15.87 35 11615 36419 110541230
Cardiac failure 44.91 15.87 75 11575 187551 110390098
Cerebral infarction 43.18 15.87 39 11611 51799 110525850
Thrombotic cerebral infarction 42.76 15.87 11 11639 783 110576866
Melaena 42.68 15.87 44 11606 68713 110508936
Vascular stent occlusion 42.21 15.87 9 11641 281 110577368
Cardiac tamponade 40.47 15.87 21 11629 11286 110566363
Platelet function test abnormal 40.25 15.87 8 11642 175 110577474
Cerebrovascular arteriovenous malformation 37.47 15.87 7 11643 109 110577540
Rhabdomyolysis 36.99 15.87 54 11596 120347 110457302
Myocardial ischaemia 36.92 15.87 27 11623 26657 110550992
Shock haemorrhagic 36.41 15.87 27 11623 27220 110550429
Cardiogenic shock 32.57 15.87 35 11615 57303 110520346
Subarachnoid haemorrhage 32.20 15.87 26 11624 29676 110547973
Pericardial haemorrhage 31.88 15.87 14 11636 5203 110572446
Aneurysm 30.68 15.87 13 11637 4433 110573216
Electrocardiogram ST segment elevation 29.91 15.87 16 11634 9144 110568505
Post procedural haemorrhage 29.26 15.87 19 11631 15493 110562156
Crush syndrome 28.92 15.87 7 11643 388 110577261
Apnoeic attack 28.39 15.87 8 11642 804 110576845
Arterial injury 28.18 15.87 8 11642 826 110576823
Abdominal symptom 27.96 15.87 8 11642 850 110576799
Drug resistance 27.86 15.87 32 11618 56342 110521307
Alopecia 27.83 15.87 3 11647 364750 110212899
Cerebellar haemorrhage 27.45 15.87 11 11639 3260 110574389
Myopathy 27.38 15.87 22 11628 24938 110552711
Phaeochromocytoma crisis 27.09 15.87 7 11643 507 110577142
Infusion related reaction 26.98 15.87 4 11646 381158 110196491
Thrombosis 26.74 15.87 44 11606 108618 110469031
Somnambulism 26.14 15.87 13 11637 6392 110571257
Myalgia 23.82 15.87 64 11586 222317 110355332
Factor V inhibition 23.78 15.87 6 11644 395 110577254
Obstructive shock 23.74 15.87 5 11645 147 110577502
Haematuria 22.32 15.87 35 11615 82970 110494679
Blood loss anaemia 22.17 15.87 17 11633 18008 110559641
Haemorrhage subcutaneous 21.89 15.87 11 11639 5528 110572121
Product administration error 21.63 15.87 23 11627 37194 110540455
Melanaemia 21.49 15.87 4 11646 61 110577588
Retroperitoneal haemorrhage 20.95 15.87 11 11639 6054 110571595
Retroperitoneal haematoma 20.84 15.87 11 11639 6120 110571529
Photopsia 20.70 15.87 11 11639 6203 110571446
Arthropathy 20.38 15.87 3 11647 287519 110290130
Bladder tamponade 20.17 15.87 6 11644 730 110576919
Cerebral vasoconstriction 19.69 15.87 7 11643 1494 110576155
Ventricular fibrillation 19.66 15.87 23 11627 41290 110536359
Intra-abdominal haemorrhage 19.34 15.87 10 11640 5332 110572317
Thrombotic thrombocytopenic purpura 19.31 15.87 11 11639 7100 110570549
Cardiac failure chronic 19.16 15.87 14 11636 13797 110563852
Ventricle rupture 19.04 15.87 4 11646 116 110577533
Tachycardia paroxysmal 18.91 15.87 5 11645 396 110577253
Hypomagnesaemia 18.42 15.87 27 11623 60343 110517306
Joint swelling 18.41 15.87 12 11638 442833 110134816
Coronary arterial stent insertion 18.38 15.87 10 11640 5905 110571744
Hypocalcaemia 18.18 15.87 28 11622 65338 110512311
Coronary artery reocclusion 18.15 15.87 4 11646 146 110577503
Hepatic function abnormal 17.85 15.87 33 11617 89262 110488387
Atrial flutter 17.78 15.87 17 11633 24245 110553404
Trunk injury 17.57 15.87 3 11647 27 110577622
Hepatitis acute 17.38 15.87 15 11635 18751 110558898
Ocular retrobulbar haemorrhage 17.32 15.87 4 11646 181 110577468
Febrile neutropenia 17.11 15.87 6 11644 316761 110260888
Coombs negative haemolytic anaemia 16.97 15.87 5 11645 589 110577060
DNA antibody negative 16.56 15.87 3 11647 39 110577610
Fatigue 16.56 15.87 69 11581 1215889 109361760
Therapeutic product effect decreased 16.31 15.87 3 11647 244313 110333336
Coagulation factor V level decreased 16.28 15.87 5 11645 678 110576971
Hyperlipasaemia 16.02 15.87 6 11644 1483 110576166
Puncture site haemorrhage 15.94 15.87 5 11645 727 110576922

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC B01AC22 BLOOD AND BLOOD FORMING ORGANS
ANTITHROMBOTIC AGENTS
ANTITHROMBOTIC AGENTS
Platelet aggregation inhibitors excl. heparin
FDA PE N0000008832 Decreased Platelet Aggregation
MeSH PA D006401 Hematologic Agents
MeSH PA D010975 Platelet Aggregation Inhibitors
FDA EPC N0000182142 P2Y12 Platelet Inhibitor
FDA MoA N0000182143 P2Y12 Receptor Antagonists
CHEBI has role CHEBI:35554 cardiovascular drug
CHEBI has role CHEBI:50433 platelet glycoprotein-IIb/IIIa receptor antagonist
CHEBI has role CHEBI:68563 P2Y<small><sub>12</sub></small> receptor antagonist
CHEBI has role CHEBI:22587 antiviral agent
CHEBI has role CHEBI:33281 antimicrobial agent
CHEBI has role CHEBI:38070 anti-arrhythmia drug
CHEBI has role CHEBI:50249 anticoagulant
CHEBI has role CHEBI:50266 prodrug
CHEBI has role CHEBI:64946 anti-HIV agent
CHEBI has role CHEBI:65023 anti-asthmatic agent
CHEBI has role CHEBI:75835 anti-anaemic agent
CHEBI has role CHEBI:231911 renoprotective agent

Related Drugs by ATC class:

B01AC Platelet aggregation inhibitors excl. heparin 24 drugs
abciximabacetylsalicylic acidaloxiprinberaprostcangrelorcarbasalate calciumcilostazolclopidogrelcloricromendipyridamoleditazoleepoprostenol show all 24 →

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Prevention of recurrence of ischemic cerebrovascular disease indication 62914000 DOID:6713
Acute coronary syndrome indication 394659003
Percutaneous coronary intervention indication 415070008
Myocardial Reinfarction Prevention indication
Intracranial hemorrhage contraindication 1386000
Acute hemorrhage contraindication 8573003
Acute peptic ulcer with hemorrhage contraindication 12274003
Low blood pressure contraindication 45007003
Hepatic failure contraindication 59927004
Blood coagulation disorder contraindication 64779008 DOID:1247
Aortocoronary artery bypass graft contraindication 67166004
Thrombotic thrombocytopenic purpura contraindication 78129009 DOID:10772
Cerebrovascular accident contraindication 230690007
Transient ischemic attack contraindication 266257000 DOID:224
Surgical procedure contraindication 387713003
Traumatic injury contraindication 417746004
Significant Bleeding contraindication




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 5.53 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
P2Y purinoceptor 12 GPCR ANTAGONIST IC50 5.75 CHEMBL CHEMBL

External reference:

IDSource
4029056 VUID
N0000179815 NUI
D05597 KEGG_DRUG
389574-19-0 SECONDARY_CAS_RN
4029056 VANDF
4029068 VANDF
C2683417 UMLSCUI
CHEBI:87715 CHEBI
CHEMBL1201772 ChEMBL_ID
DB06209 DRUGBANK_ID
CHEMBL1201773 ChEMBL_ID
D000068799 MESH_DESCRIPTOR_UI
6918456 PUBCHEM_CID
7562 IUPHAR_LIGAND_ID
8503 INN_ID
34K66TBT99 UNII
613391 RXNORM
166281 MMSL
261080 MMSL
26287 MMSL
39620 MMSL
d07409 MMSL
012994 NDDF
012995 NDDF
443129001 SNOMEDCT_US
443312008 SNOMEDCT_US
735166002 SNOMEDCT_US
34K66TBT99 INXIGHT DRUGS

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 0378-5185 TABLET, FILM COATED 5 mg ORAL ANDA 29 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 0378-5186 TABLET, FILM COATED 10 mg ORAL ANDA 29 sections
PRASUGREL HUMAN PRESCRIPTION DRUG LABEL 1 0440-0604 TABLET, FILM COATED 5 mg ORAL ANDA 29 sections
PRASUGREL HUMAN PRESCRIPTION DRUG LABEL 1 0440-0605 TABLET, FILM COATED 10 mg ORAL ANDA 29 sections
Effient HUMAN PRESCRIPTION DRUG LABEL 1 0713-0881 TABLET, COATED 5 mg ORAL NDA 33 sections
Effient HUMAN PRESCRIPTION DRUG LABEL 1 0713-0882 TABLET, COATED 10 mg ORAL NDA 33 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 16729-272 TABLET, FILM COATED 5 mg ORAL ANDA 27 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 16729-273 TABLET, FILM COATED 10 mg ORAL ANDA 27 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 29300-301 TABLET, FILM COATED 5 mg ORAL ANDA 22 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 29300-302 TABLET, FILM COATED 10 mg ORAL ANDA 22 sections
PRASUGREL HUMAN PRESCRIPTION DRUG LABEL 1 43817-239 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
PRASUGREL HUMAN PRESCRIPTION DRUG LABEL 1 43817-240 TABLET, FILM COATED 10 mg ORAL ANDA 26 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 50090-5169 TABLET, FILM COATED 10 mg ORAL ANDA 27 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 51407-444 TABLET, FILM COATED 5 mg ORAL ANDA 29 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 51407-445 TABLET, FILM COATED 10 mg ORAL ANDA 29 sections
Effient HUMAN PRESCRIPTION DRUG LABEL 1 54868-6238 TABLET, FILM COATED 10 mg ORAL NDA 28 sections
PRASUGREL HUMAN PRESCRIPTION DRUG LABEL 1 60505-4642 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
PRASUGREL HUMAN PRESCRIPTION DRUG LABEL 1 60505-4643 TABLET, FILM COATED 10 mg ORAL ANDA 26 sections
PRASUGREL HUMAN PRESCRIPTION DRUG LABEL 1 60505-4856 TABLET, FILM COATED 10 mg ORAL ANDA 26 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 60687-883 TABLET, FILM COATED 10 mg ORAL ANDA 27 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 63629-4829 TABLET, FILM COATED 10 mg ORAL ANDA 27 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 65162-001 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
Prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 65162-002 TABLET, FILM COATED 10 mg ORAL ANDA 26 sections
Prasugrel Human Prescription Drug Label 1 65862-829 TABLET, FILM COATED 5 mg ORAL ANDA 27 sections
Prasugrel Human Prescription Drug Label 1 65862-830 TABLET, FILM COATED 10 mg ORAL ANDA 27 sections
PRASUGREL HUMAN PRESCRIPTION DRUG LABEL 1 67877-604 TABLET, FILM COATED 5 mg ORAL ANDA 28 sections
PRASUGREL HUMAN PRESCRIPTION DRUG LABEL 1 67877-605 TABLET, FILM COATED 10 mg ORAL ANDA 28 sections
prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 68180-795 TABLET, FILM COATED 5 mg ORAL ANDA 26 sections
prasugrel HUMAN PRESCRIPTION DRUG LABEL 1 68180-796 TABLET, FILM COATED 10 mg ORAL ANDA 26 sections